forgemax.FORGED. TESTED. PROVEN.
MELANOTAN-2 20mg/vial 1 Vial by Bluepeps
Batch Tested

MELANOTAN-2 20mg/vial 1 Vial by Bluepeps

Bluepeps Melanotan 2 is a synthetic melanocortin-receptor agonist supplied as 20 mg lyophilised peptide per vial — the highest concentration available in this range — uniquely suited for use during a bridge or PCT phase because it does not engage the hypothalamic-pituitary-gonadal axis and therefore carries no suppressive risk to endogenous hormone recovery. Athletes bridging between cycles can leverage its melanocortin-mediated effects on tissue and appetite without compromising the hormonal rebound that PCT depends on. Batch-released quality is enforced through a dual-gate protocol: reversed-phase HPLC confirms sequence integrity and active-content accuracy; a Limulus Amebocyte Lysate assay independently verifies that endotoxin load sits within defined safety limits.

€50.00Free shipping on orders over €300
In stock
Ships within 48 h Lab-tested batch
  • Axis-neutral melanocortin agonist — no interference with LH, FSH or testosterone recovery during PCT
  • 20 mg per vial delivers up to 80 administrations at a 0.25 mg dose, maximising bridge-phase economy
  • MC receptor-mediated anti-inflammatory potential supports connective tissue during the post-cycle window
  • Appetite-regulation signalling through MC4R assists caloric control when catabolism risk is highest
  • Lyophilised format maintains peptide stability through cold-chain without degradation risk
  • Batch Tested: HPLC sequence verification and LAL endotoxin screening before every lot release
  • Inert-atmosphere vial sealing protects lyophilised cake integrity from oxidative damage in transit

Key takeaways

  • Use Melanotan 2 during PCT without risking hormonal axis suppression.
  • Leverage melanocortin receptor activation to support joint comfort post-cycle.
  • Dose precisely from the 20mg vial — highest concentration in this range.
  • Combine with GH secretagogues for complementary, non-overlapping bridge coverage.
  • Verify every lot via Batch Tested HPLC and LAL endotoxin release gates.

Melanotan 2 as a Hormonally Neutral Bridge Peptide

Bluepe's Melanotan 2 is a cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone that activates melanocortin receptor subtypes — primarily MC1R and MC4R — without interacting with androgen, oestrogen or gonadotrophin signalling pathways, making it one of the few peptides genuinely compatible with an uninterrupted PCT protocol. Compared to GH secretagogues used in bridge phases, Melanotan 2 adds a complementary mechanistic layer: while secretagogues work through GH pulse amplification, MT-2 operates entirely within the melanocortin system, meaning the two classes can be combined without pathway overlap or compounded suppression risk. Bluepeps supplies this compound at 20 mg per vial — the highest single-vial concentration in the current product group — giving users a cost-efficient format during the multi-week bridge window.

Joint and Muscle Retention During the Inter-Cycle Period

Maintaining connective tissue integrity is a recognised challenge when anabolic support is withdrawn at the end of a cycle. Melanocortin receptor activation has been associated with anti-inflammatory signalling in preclinical models, a mechanism that may contribute to reduced joint discomfort during the low-androgen environment of PCT. Melanotan 2 preserves appetite-regulation signalling through MC4R engagement, which supports caloric intake discipline at a phase when muscle catabolism risk is elevated. Three semantic anchors define its bridge utility: Melanotan 2 activates melanocortin receptors without suppressing LH or FSH; the peptide format requires no liver-first-pass metabolism; and HPLC-confirmed 20 mg dosing enables precise, consistent administration across a full bridge period.

Quality Infrastructure Behind Every Vial

Each Bluepeps Melanotan 2 lot undergoes reversed-phase HPLC sequence analysis to validate both amino-acid fidelity and active-content accuracy against the declared 20 mg specification, followed by a LAL endotoxin screen that quantifies residual pyrogenic load before release authorisation is issued. Vials are lyophilised under ISO-classified cleanroom conditions and sealed under inert atmosphere to protect peptide stability throughout cold-chain transit. A lot-specific certificate of analysis — generated after both analytical gates pass — accompanies every batch, giving buyers traceable confirmation of the Batch Tested standard applied to this product.

Usage

  1. Confirm cold storage: retrieve the Bluepeps Melanotan 2 vial from 2–8 °C refrigeration and allow it to reach room temperature for 5 minutes before reconstitution to reduce thermal shock to the peptide.
  2. Reconstitute with bacteriostatic water using a fresh needle; add liquid slowly down the inner glass wall to preserve the lyophilised cake structure, then swirl — never agitate — until fully dissolved.
  3. Calculate your bridge or PCT dose against the vial's total active content (20 mg); use a calibrated insulin syringe (29–31 gauge, 0.5 mL) for sub-milligram precision critical during a PCT concurrent protocol.
  4. Administer subcutaneously — lower abdomen is preferred — in the evening during the bridge phase; evening dosing aligns with natural appetite-suppression windows and reduces daytime nausea incidence.
  5. Log each administration date and dose in a simple tracking sheet; during PCT, co-administration timing relative to SERM dosing should be staggered by at least 30 minutes for practical management.
  6. After each use, recap the vial immediately and return to refrigeration at 2–8 °C; label with reconstitution date and discard after 28 days regardless of remaining volume.

Warnings

Contraindications: Do not use if you have a personal or family history of melanoma, dysplastic naevus syndrome, or any active pigmented skin lesion under dermatological surveillance. Individuals with cardiovascular conditions should exercise caution given MC4R-mediated haemodynamic effects. Pregnancy and breastfeeding: contraindicated — no safety data exists.

Side_Effects: Most commonly reported: transient facial flushing, nausea and spontaneous erections — all dose-dependent and typically resolve within 1–2 hours of administration. Increased mole darkness or new pigmentation changes warrant dermatological review before continuing use. Yawning and fatigue are occasionally reported during loading.

Monitoring: Conduct a full-body skin check before starting and every 4 weeks during use; photograph any changing lesions for comparative reference. Monitor blood pressure at baseline and mid-bridge if cardiovascular risk factors are present. Track appetite changes and body weight weekly during PCT concurrent use to catch unexpected catabolism early.

PCT: Melanotan 2 carries no suppressive effect on the HPG axis and is pharmacologically compatible with standard PCT agents including SERMs (tamoxifen, clomiphene) and aromatase inhibitors. No dose adjustment of PCT medications is required when co-administering MT-2. Discontinue Melanotan 2 at the end of PCT if the bridge objective has been achieved.

Frequently asked questions

Can Melanotan 2 be used during PCT without interfering with hormone recovery?
Yes — Melanotan 2 does not interact with the hypothalamic-pituitary-gonadal axis, so it cannot suppress LH, FSH or endogenous testosterone recovery. This axis-neutral profile is precisely what makes it suitable during PCT, where any suppressive compound would counteract the hormonal rebound you are trying to achieve. It operates exclusively through melanocortin receptor subtypes, leaving gonadotrophin signalling untouched.
Which peptides are genuinely suitable for a bridge phase between cycles?
Bridge-compatible peptides are those that provide physiological benefit without engaging suppressive pathways. Melanotan 2 qualifies because it targets MC1R and MC4R rather than androgen or GH-axis receptors. GH secretagogues such as Ipamorelin can complement it during a bridge by addressing GH pulse frequency, while MT-2 handles melanocortin-mediated functions — the two classes do not overlap mechanistically.
How does Melanotan 2 help protect joints after coming off a cycle?
Preclinical research links melanocortin receptor activation to anti-inflammatory signalling cascades that may reduce joint discomfort during the low-androgen environment following a cycle. While not a dedicated joint compound, MT-2's MC receptor activity provides a complementary anti-inflammatory input at a phase when connective tissue is most vulnerable due to the withdrawal of anabolic support.
Why is the 20mg/vial concentration an advantage for a bridge or PCT protocol?
A 20 mg vial is the highest concentration available in this product group and allows flexible, extended dosing across a full 4–6 week bridge or PCT window without frequent vial changes. Typical bridge protocols use 0.25–0.5 mg per administration; a single 20 mg vial provides approximately 40–80 administrations, making it substantially more cost-efficient per dose than lower-concentration formats.
How should a Bluepeps Melanotan 2 20mg vial be stored after reconstitution?
Once reconstituted with bacteriostatic water, the vial must be refrigerated at 2–8 °C and kept away from direct light. Use an insulin syringe (typically 0.5 mL / 29–31 gauge) for accurate sub-milligram dosing. Draw the required volume carefully to avoid introducing air bubbles. Discard any unused reconstituted solution after 28 days; the lyophilised unreconstituted vial should be stored frozen until use. (2) angle_used

Manufacturer

Bluepeps prices its Melanotan 2 20 mg vial within a deliberate access strategy: a single high-concentration format replaces the need for multiple lower-dose vials across a full bridge or PCT window, compressing per-dose cost without reducing analytical rigour. Affordability at Bluepeps is not achieved by cutting quality steps — the same two-gate release protocol applied across the entire peptide catalogue governs this vial; reversed-phase HPLC confirms active-content accuracy against the declared 20 mg specification, and a Limulus Amebocyte Lysate endotoxin assay independently clears each lot before it enters distribution. Pricing transparency extends to documentation: a lot-specific certificate of analysis is generated post-clearance and remains traceable to the exact batch number printed on the vial, giving buyers a verifiable audit trail rather than a generic quality claim.

Product details

BrandBluepeps
Active ingredientmelanotan 2
Also known asMT-2, Bio-Peptide Melanotan II, MELANOTAN-2, Bluepeps MT-2
Strength20 mg
FormVial
Pack size1 piece
Item numberPEPT-MEL2-BLU-003

Reviews

No reviews yet. Be the first to review this product.

Write a review

Your rating *

Your review will be checked before publication.

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

MT-2 10mg/vial 1 Vial by Bio-PeptideLab Tested

MT-2 10mg/vial 1 Vial by Bio-Peptide

€36.00
Melanotan 2 10mg/vial 1 Vial by Knoll PharmaceuticalsHPLC Verified

Melanotan 2 10mg/vial 1 Vial by Knoll Pharmaceuticals

€30.00
Melanton IITop Seller

Melanton II 10mg/vial 1 Vial by Master Pharma

€35.00

Stack it with

Pairs well with these products.

Quant-Equipoise 300mg/ml 10ml Vial by Beligas PharmaceuticalsHigh Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

€47.00
Bolden-250 250mg/ml 10x1ml Ampoules by BM PharmaceuticalsLong-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

€48.00
EquiTrex 350mg/ml 10ml Vial by Concentrex LabsBrand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

€52.00
EQ 300 300mg/ml 10ml Vial by Dragon-PharmaPro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

€44.00